Partnership brings first-in-class IL-15 receptor agonist immunotherapy to patients in Israel Israeli Ministry of Health grants approval for ANKTIVA® (nogapendekin alfa inbakicept) in combination ...
Industry organisation Business Leadership South Africa (BLSA) has affirmed that business stands ready to support capable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results